Hypothyroidism alters striatal dopamine release mediated by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)

Synapse

Volumn 59, Issue 5, 2006, Pages 317-319

  Peterson, Andrea L ^a,b   Gilman, Tracy L ^a,b   Banks, Matthew L ^c   Sprague, Jon E ^a,b  

^a EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Hyperthermia; Hypothermia; Microdialysis

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; DOPAMINE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; CORPUS STRIATUM; DOPAMINE RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTHERMIA; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; HYPOTHERMIA; HYPOTHYROIDISM; MALE; MICRODIALYSIS; NONHUMAN; PARATHYROIDECTOMY; PRIORITY JOURNAL; RAT; THERMOREGULATION; THYROIDECTOMY;

ANALYSIS OF VARIANCE; ANIMALS; BODY TEMPERATURE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; DRUG INTERACTIONS; ELECTROCHEMISTRY; HALLUCINOGENS; HYPOTHYROIDISM; MALE; MICRODIALYSIS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; THYROIDECTOMY; TIME FACTORS;

EID: 33144468889     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20244     Document Type: Article

References (13)

1. Bowyer JF, Gough B, Slikker W, Lipe GW, Newport GD, Holson RR. 1993. Effects of a cold environment or age on methamphetamine-induced dopamine release in the caudate putamen of female rats. Pharm Bio Behav 44:87-98.
2. Chapin DS, Lookingland KJ, Moore KE. 1994. Effects of LC mobile phase composition on retention times for biogenic amines, and their precursors and metabolites. Curr Sep 7:68-70.
3. Falk EM, Cook VJ, Nichols DE, Sprague JE. 2002. An antisense nucleotide targeted at MAO-B attenuates rat striatal serotonergic neurotoxicity induced by MDMA. Pharmacol Biochem Behav 72:617-622.
4. Green AR, Mechan AO, Elliot JM, O'Shea E, Colado MI. 2003. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55:463-508.
5. Jones DC, Lau SS, Monks TJ. 2004. Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC Cells. J Pharmacol Exp Ther 311:298-306.
6. Mechan AO, Esteban B, O'Shea E, Elliot JM, Colado MI, Green AR. 2002. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") to rats. Br J Pharmacol 135:170-180.
7. Nash JF, Nichols DE. 1991. Microdialysis studies on 3,4- methylenedioxyamphetamine and structurally related analogues. Euro J Pharmacol 200:53-58.
8. O'Shea E, Escobedo I, Orio L, Sanchez V, Navarro M, Green AR, Colado MI. 2005. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats. Neuropsychopharmacol 30:1312-1323.
9. Overstreet DH, Crocker AD, Lawson CA, McIntosh GH, Crocker JM. 1984. Alterations in the dopaminergic system and behaviour, in rats reared on iodine-deficient diets. Pharmacol Biochem Behav 21:561-565.
10. Schmidt CJ, Black CK, Taylor VL. 1990. Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine. Eur J Pharm 181:59-70.
11. Sprague JE, Everman SL, Nichols DE. 1998. An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. Neurotoxicology 19:427-441.
12. Sprague JE, Banks ML, Cook VJ, Mills EM. 2003. Hypothalamic-pituitary- thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy). J Pharmacol Exp Ther 305:159-166.
13. Yamamoto BK, Spanos LJ. 1988. The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat. Eur J Pharmacol 148:195-203.